국가: 말레이시아
언어: 영어
출처: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
PERINDOPRIL ARGININE
SERVIER MALAYSIA SDN BHD
PERINDOPRIL ARGININE
10 mcg/mL; 30 mcg/mL
LES LABS SERVIER INDUSTRIE
Consumer Medication Information Leaflet (RiMUP) 1 COVERSYL 10MG TABLET FILEM BERSALUT Perindopril arginine 10mg DALAM SISIP BUNGKUSAN INI 1. Apa itu COVERSYL 10mg dan kegunaannya 2. Bagaimana COVERSYL 10mg berfungsi 3. Sebelum mengambil COVERSYL 10mg 4. Cara menggunakan COVERSYL 10mg 5. Semasa mengambil COVERSYL 10mg 6. Kesan-kesan sampingan COVERSYL 10mg 7. Penyimpanan dan pelupusan COVERSYL 10mg 8. Maklumat lanjut 9. Pengilang dan pemegang pendaftaran produk 10. Tarikh kemaskini APA ITU COVERSYL 10MG DAN KEGUNAANNYA Coversyl 10mg ialah penghalang enzim penukar angiotensin (“ _ACE _ _inhibitor_ ”). Coversyl 10mg digunakan: - untuk rawatan _TEKANAN _ _DARAH _ _TINGGI_ , - untuk mengurangkan risiko masalah jantung, seperti serangan jantung, dalam pesakit-pesakit yang mempunyai _PENYAKIT ARTERI _ _KORONARI STABIL_ (di mana bekalan darah ke jantung telah kurang atau terhalang) dan pernah mengalami satu serangan jantung dan / atau menjalani pembedahan pembesaran saluran darah untuk meningkatkan bekalan darah ke jantung. BAGAIMANA COVERSYL 10MG BERFUNGSI Coversyl 10mg ialah penghalang enzim penukar angiotensin (“ACE inhibitor”). Ia bertindak dengan membesarkan saluran darah, seterusnya memudahkan jantung anda mengepam darah menerusinya. SEBELUM MENGAMBIL COVERSYL 10MG - _Bila tidak boleh mengambil _ JANGAN MENGAMBIL COVERSYL 10MG - jika anda alah (hipersensitif) terhadap perindopril atau ACE inhibitor yang lain atau sebarang kandungan dalam Coversyl 10mg (yang disenaraikan di Seksyen 8), - jika anda telah mengalami simptom seperti kesukaran bernafas, bengkak muka, lidah atau kerongkong, gatal yang teruk atau alahan kulit yang teruk dengan rawatan ACE inhibitor yang sebelumnya atau ahli keluarga anda mempunyai simptom tersebut (keadaan yang dipanggil ‘ _angioedema_ ’), - jika anda telah mengandung lebih dari 3 bulan. (Adalah lebih baik mengelak Coversyl 10mg pada awal kehamilan – (lihat seksyen kehamilan), - jika anda mempunyai kencing manis atau fungsi buah pinggang yang rosak dan anda dirawat dengan uba 전체 문서 읽기
_Final PI_Coversyl_10mg_17.05.2022 _ _1 _ USED IN PREGNANCY When used in pregnancy during the second and third trimesters, ACE inhibitors can cause injury and even death to the developing fetus. When pregnancy is detected this drug should be discontinued as soon as possible 1. NAME OF THE MEDICINAL PRODUCT Coversyl 10 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Perindopril arginine. One film-coated tablet contains 6.790 mg perindopril corresponding to 10 mg perindopril arginine. Excipient with known effect: 145.16 mg lactose monohydrate. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet. Green, round, biconvex, film-coated tablet engraved with on one face and on the other face. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Hypertension Treatment of hypertension. Stable coronary artery disease Reduction of risk of cardiac events in patients with a history of myocardial infarction and/or revascularisation. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY The dose should be individualised according to the patient profile (see section 4.4) and blood pressure response. _Final PI_Coversyl_10mg_17.05.2022 _ _2 _ Hypertension Coversyl may be used in monotherapy or in combination with other classes of antihypertensive therapy (see sections 4.3, 4.4, 4.5 and 5.1). The recommended starting dose is 5 mg given once daily _ _ in the morning. Patients with a strongly activated renin-angiotensin-aldosterone system (in particular, renovascular hypertension, salt and/or volume depletion, cardiac decompensation or severe hypertension) may experience an excessive drop in blood pressure following the initial dose. A starting dose of 2.5 mg is recommended in such patients and the initiation of treatment should take place under medical supervision. The dose may be increased to 10 mg once daily after one month of treatment. Symptomatic hypotension may occur following initiation of therapy with Coversyl; this is more likely in patients who are being treated concurre 전체 문서 읽기